Rifampin
Rifampin is a pharmaceutical drug with 169 clinical trials. Currently 10 active trials ongoing. Historical success rate of 94.4%.
Success Metrics
Based on 134 completed trials
Phase Distribution
Phase Distribution
119
Early Stage
21
Mid Stage
18
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.2%
134 of 147 finished
8.8%
13 ended early
10
trials recruiting
169
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Shortened Regimen for Drug-susceptible TB in Children
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants
Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
Clinical Trials (169)
Shortened Regimen for Drug-susceptible TB in Children
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants
Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)
Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects
Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
Short-course Regimens for the Treatment of Pulmonary Tuberculosis
Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 169